Compare RZLT & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RZLT | EHTH |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.4M | 104.0M |
| IPO Year | 2011 | 2006 |
| Metric | RZLT | EHTH |
|---|---|---|
| Price | $2.55 | $1.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $9.17 | $3.33 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 05-27-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.32 | ★ 71.43 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $251,395,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 45.86 |
| 52 Week Low | $1.07 | $1.20 |
| 52 Week High | $11.46 | $7.79 |
| Indicator | RZLT | EHTH |
|---|---|---|
| Relative Strength Index (RSI) | 33.21 | 39.81 |
| Support Level | $1.87 | $1.20 |
| Resistance Level | $2.82 | $1.93 |
| Average True Range (ATR) | 0.25 | 0.16 |
| MACD | -0.07 | 0.08 |
| Stochastic Oscillator | 10.16 | 51.56 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.